Therapeutic Landscape of Acute Myeloid Leukemia in 2019 - Intensive Therapy

Learning Objectives

  • Understand treatment paradigm for adult AML patients.
  • Understand benefits of intensified Daunorubicin dose induction therapy
  • Understand benefits of newly approved agents by FDA for AML
  • Understand the role of Allo HSCT in AML patients
Course summary
Available credit: 
  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
Registration Opens: 
01/16/2020
Registration Expires: 
01/15/2022
Part of: 
Advanced Practice Provider Webinar Lecture Series 2020
Rating: 
0

Available Credit

  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
Please login or register to take this course.